Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Citations 0
March 25, 1998

Incorrect Wording

JAMA. 1998;279(12):913. doi:10.1001/jama.279.12.913

In the From the Food and Drug Administration column published in the February 4, 1998, issue of THE JOURNAL (1998;279:346), there was incorrect wording under the heading "Two New Warnings Added to Labeling for Mibefradil." Mibrefadil is not contraindicated for patients concurrently receiving fluvastatin. The 2 drugs for which a new warning states that concurrent use with Mibefradil is contraindicated are lovastatin and simvastatin.